Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login
New here? Get 10% off with code WELCOME10

Onglyza (Saxagliptin) 2.5mg, 5mg Side Effects

Share Post:

Onglyza (Saxagliptin) Side Effects

The possible side effects of the drug are:

  • Upper respiratory tract infection
  • Urinary tract infection
  • Headache
  • Runny nose
  • Sore throat
  • Cough

The above Onglyza side effects are normally mild and clear after the body become used to the drug. If they are more serious or don’t go way, consult the pharmacist or the physician. As for the severe side effects, contact the medical care provider; if the signs are fatal or if you think you are experiencing a medical emergency.

Such negative effects include:

  • Pancreatitis
  • Allergic reactions
  • Fevers and chills
  • Painful urination
  • Swelling of the ankles, feet, and hands
  • Unusual abdominal pain
  • Vomiting
  • Reduction of white blood cells levels
  • Heart failure

The use of the drug hasn’t been established while one is pregnant. It’s recommended to avoid taking the drug during pregnancy unless considered important by the physician. Saxagliptin side effects are almost similar to other medicines which fall under the category of DPP-4 inhibitors like Januvia and Tradjenta.

In Conclusion

Anyone is at risk of unwanted effects if the drug is not taken as directed or prescribed. If a patient takes it in skipped doses or do not take it all, the blood glucose will get high and diabetes may worsen. Taking an overdose may trigger low blood sugar, thus follow the doctor’s prescription.

Doctor’s Recommendation

DPP4 inhibitors have less efficacy than GLP-1 agonists. However, they may be good additions for individuals with renal impairment who need additional glucose reduction despite being on other glucose-lowering medications.

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Medically Reviewed

Profile image of Dr Pawel Zawadzki

Medically Reviewed By Dr Pawel ZawadzkiDr. Pawel Zawadzki, a U.S.-licensed MD from McMaster University and Poznan Medical School, specializes in family medicine, advocates for healthy living, and enjoys outdoor activities, reflecting his holistic approach to health.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on April 20, 2021

Related Products

Promotion
Ozempic
  • In Stock
  • Express Shipping
New Lower Price
Mounjaro Vial
  • In Stock
  • Express Shipping
Rybelsus
  • In Stock
  • Express Shipping
Promotion
Humalog Vial
  • In Stock
  • Express Shipping

Related Articles

Diabetes, Insulin, Type
Premixed Insulin: How It Works and What to Know

Managing blood sugar effectively remains the cornerstone of preventing long-term complications, and insulin therapy plays a vital role in this effort. While many patients are familiar with basal and bolus…

Read More
Type 2 Diabetes,
Diet and Weight Loss in the Age of GLP-1 Medications

The science of diet and weight loss has changed dramatically in recent years. What used to be a slow process of trial and error with food plans and workouts has…

Read More
Diabetes, Type 2
Orforglipron vs Tirzepatide – A Complete Comparison Guide

Obesity and type 2 diabetes continue to affect millions of Americans, with more than 40 percent of adults in the U.S. classified as obese according to the Centers for Disease…

Read More
Diabetes, Type 2
Orforglipron Pill: Could This Experimental Drug Work?

Obesity is a major public health issue in the United States. According to the Centers for Disease Control and Prevention (CDC), more than 40 percent of adults are classified as…

Read More